{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:23:28Z","timestamp":1780345408291,"version":"3.54.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Government Department of Higher Education"},{"DOI":"10.13039\/501100001232","name":"Royal Australasian College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11904-025-00768-7","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:48:09Z","timestamp":1766548089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mycoplasma Genitalium \u2013 Where are we at?"],"prefix":"10.1007","volume":"22","author":[{"given":"Catriona S.","family":"Bradshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Htaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka A.","family":"Vodstrcil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"5","key":"768_CR1","first-page":"319","volume":"61","author":"D Taylor-Robinson","year":"1985","unstructured":"Taylor-Robinson D, Furr PM, Hanna NF. Microbiological and serological study of non-gonococcal urethritis with special reference to Mycoplasma genitalium. Genitourin Med. 1985;61(5):319\u201324.","journal-title":"Genitourin Med"},{"issue":"7","key":"768_CR2","doi-asserted-by":"publisher","first-page":"002040","DOI":"10.1099\/jmm.0.002040","volume":"74","author":"JL Huaman","year":"2025","unstructured":"Huaman JL, Bradshaw CS, Chua TP, Plummer EL, Danielewski JA, Vodstrcil LA, Jensen JS, Garland SM, Wild N, Murray GL. Factors that contribute to the success of primary isolation of Mycoplasma genitalium from clinical samples. J Med Microbiol. 2025;74(7):002040.","journal-title":"J Med Microbiol"},{"issue":"1","key":"768_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1128\/JCM.41.1.261-266.2003","volume":"41","author":"JS Jensen","year":"2003","unstructured":"Jensen JS, Borre MB, Dohn B. Detection of Mycoplasma genitalium by PCR amplification of the 16S rRNA gene. J Clin Microbiol. 2003;41(1):261\u20136.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"768_CR4","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/ije\/dyv194","volume":"44","author":"P Sonnenberg","year":"2015","unstructured":"Sonnenberg P, Ison CA, Clifton S, Field N, Tanton C, Soldan K, Beddows S, Alexander S, Khanom R, Saunders P, et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16\u201344 years: evidence from the third National survey of sexual attitudes and lifestyles (Natsal-3). Int J Epidemiol. 2015;44(6):1982\u201394.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"768_CR5","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1097\/OLQ.0000000000001394","volume":"48","author":"EA Torrone","year":"2021","unstructured":"Torrone EA, Kruszon-Moran D, Philips C, Morris MR, Bowden KE, Papp J, et al. Prevalence of urogenital Mycoplasma genitalium infection, united States, 2017 to 2018. Sex Transm Dis. 2021;48(11):e160-2.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"768_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/cid\/ciu217","volume":"59","author":"K Salado-Rasmussen","year":"2014","unstructured":"Salado-Rasmussen K, Jensen JS. Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis. 2014;59(1):24\u201330.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"768_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/sti.2006.022970","volume":"83","author":"B Andersen","year":"2007","unstructured":"Andersen B, Sokolowski I, Ostergaard L, Kjolseth Moller J, Olesen F, Jensen JS. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect. 2007;83(3):237\u201341.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"768_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3201\/eid2504.181258","volume":"25","author":"TRH Read","year":"2019","unstructured":"Read TRH, Murray GL, Danielewski JA, Fairley CK, Doyle M, Worthington K, Su J, Mokany E, Tan LT, Lee D, et al. Symptoms, Sites, and significance of Mycoplasma genitalium in men who have sex with men. Emerg Infect Dis. 2019;25(4):719\u201327.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"768_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2004.00923.x","volume":"18","author":"JS Jensen","year":"2004","unstructured":"Jensen JS. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol. 2004;18(1):1\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"768_CR10","doi-asserted-by":"publisher","first-page":"ciae295","DOI":"10.1093\/cid\/ciae295","volume":"Online ahead of","author":"K Htaik","year":"2024","unstructured":"Htaik K, Vodstrcil LA, Plummer EL, Sfameni AM, Machalek DA, Manhart LE, Bradshaw CS. Systematic review and meta-analysis of the association between Mycoplasma genitalium and pelvic inflammatory disease (PID). Clin Infect Dis. 2024;Online ahead of print:ciae295.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"768_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/cid\/civ312","volume":"61","author":"R Lis","year":"2015","unstructured":"Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61(3):418\u201326.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"768_CR12","doi-asserted-by":"publisher","first-page":"e220094","DOI":"10.3201\/eid2808.220094","volume":"28","author":"LE Manhart","year":"2022","unstructured":"Manhart LE, Geisler WM, Bradshaw CS, Jensen JS, Martin DH. Weighing potential benefits and harms of Mycoplasma genitalium testing and treatment approaches. Emerg Infect Dis. 2022;28(8):e220094.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"768_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41579-024-01023-3","volume":"22","author":"JS Jensen","year":"2024","unstructured":"Jensen JS, Unemo M. Antimicrobial treatment and resistance in sexually transmitted bacterial infections. Nat Rev Microbiol. 2024;22(7):435\u201350.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"768_CR14","doi-asserted-by":"publisher","first-page":"001984","DOI":"10.1099\/jmm.0.001984","volume":"74","author":"T Rudman","year":"2025","unstructured":"Rudman T, Rowlands RS, Jensen JS, Beeton ML, On Behalf Of The Escmid Study Group, For M, Chlamydia Infections E. JMM profile: Mycoplasma genitalium: a small, yet significant pathogen. J Med Microbiol. 2025;74(4):001984.","journal-title":"J Med Microbiol"},{"key":"768_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12879-015-1041-6","volume":"15","author":"JS Jensen","year":"2015","unstructured":"Jensen JS, Bradshaw C. Management of Mycoplasma genitalium infections - can we hit a moving target? BMC Infect Dis. 2015;15:343.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"768_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/cid\/civ644","volume":"61","author":"A Lau","year":"2015","unstructured":"Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FY, et al. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis. 2015;61(9):1389\u201399.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"768_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid1207.051558","volume":"12","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw CS, Jensen JS, Tabrizi SN, Read TR, Garland SM, Hopkins CA, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis. 2006;12(7):1149\u201352.","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"768_CR18","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1086\/593188","volume":"47","author":"JS Jensen","year":"2008","unstructured":"Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis. 2008;47(12):1546\u201353.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"768_CR19","doi-asserted-by":"publisher","first-page":"e3618","DOI":"10.1371\/journal.pone.0003618","volume":"3","author":"CS Bradshaw","year":"2008","unstructured":"Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One. 2008;3(11):e3618.","journal-title":"PLoS One"},{"issue":"7","key":"768_CR20","doi-asserted-by":"publisher","first-page":"101047","DOI":"10.1016\/j.lanmic.2024.101047","volume":"6","author":"TP Chua","year":"2025","unstructured":"Chua TP, Vodstrcil LA, Murray GL, Plummer EL, Jensen JS, Unemo M, Chow EPF, Low N, Whiley DM, Sweeney EL, et al. Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis. Lancet Microbe. 2025;6(7):101047.","journal-title":"Lancet Microbe"},{"key":"768_CR21","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.lanepe.2023.100737","volume":"34","author":"O Mitja","year":"2023","unstructured":"Mitja O, Suner C, Giacani L, Vall-Mayans M, Tiplica GS, Ross JDC, Bradshaw CS. Treatment of bacterial sexually transmitted infections in europe: gonorrhoea, Mycoplasma genitalium, and syphilis. Lancet Reg Health Eur. 2023;34:100737.","journal-title":"Lancet Reg Health Eur"},{"key":"768_CR22","unstructured":"World Health Organisation guidelines for the management of symptomatic sexually transmitted infections. 2021 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34370424"},{"issue":"10","key":"768_CR23","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jiac.2021.07.007","volume":"27","author":"K Wada","year":"2021","unstructured":"Wada K, Hamasuna R, Sadahira T, Araki M, Yamamoto S. UAA-AAUS guideline for M. genitalium and non-chlamydial non-gonococcal urethritis. J Infect Chemother. 2021;27(10):1384\u20138.","journal-title":"J Infect Chemother"},{"issue":"1","key":"768_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4111\/icu.20230314","volume":"65","author":"SJ Lee","year":"2024","unstructured":"Lee SJ, Choi JB, Bae S, Na SW, Jung HD, Jung HJ, et al. 2023 Korean sexually transmitted infections treatment guidelines for Mycoplasma genitalium by KAUTII. Investig Clin Urol. 2024;65(1):16\u201322.","journal-title":"Investig Clin Urol"},{"issue":"5","key":"768_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/jdv.17972","volume":"36","author":"JS Jensen","year":"2022","unstructured":"Jensen JS, Cusini M, Gomberg M, Moi H, Wilson J, Unemo M. 2021 European guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022;36(5):641\u201350.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"768_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1071\/SH22134","volume":"20","author":"JJ Ong","year":"2023","unstructured":"Ong JJ, Bourne C, Dean JA, Ryder N, Cornelisse VJ, Murray S, Kenchington P, Moten A, Gibbs C, Maunsell S, et al. Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update. Sex Health. 2023;20(1):1\u20138.","journal-title":"Sex Health"},{"issue":"4","key":"768_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1\u2013187.","journal-title":"MMWR Recomm Rep"},{"key":"768_CR28","doi-asserted-by":"crossref","unstructured":"Soni S, Fifer H, Al-Shakarchi Y, Bassett J, Mbaulu J, Pinto-Sander N, Strodtbeck S, Rayment M. British Association of Sexual Health and HIV National guideline for the management of infection with Mycoplasma genitalium, 2025. Int J STD AIDS 2025: on line ahead of print.","DOI":"10.1177\/09564624251359054"},{"issue":"8","key":"768_CR29","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/cid\/ciu1162","volume":"60","author":"M Bissessor","year":"2015","unstructured":"Bissessor M, Tabrizi SN, Twin J, Abdo H, Fairley CK, Chen MY, Vodstrcil LA, Jensen JS, Hocking JS, Garland SM, et al. Macrolide resistance and Azithromycin failure in a Mycoplasma genitalium-infected cohort and response of Azithromycin failures to alternative antibiotic regimens. Clin Infect Dis. 2015;60(8):1228\u201336.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"768_CR30","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3201\/eid2305.161745","volume":"23","author":"GL Murray","year":"2017","unstructured":"Murray GL, Bradshaw CS, Bissessor M, Danielewski J, Garland SM, Jensen JS, et al. Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium. Emerg Infect Dis. 2017;23(5):809\u201312.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"768_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jiac.2017.03.008","volume":"23","author":"T Deguchi","year":"2017","unstructured":"Deguchi T, Ito S, Yasuda M, Kondo H, Yamada Y, Nakane K, et al. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and parC in Japan. J Infect Chemother. 2017;23(9):648\u201350.","journal-title":"J Infect Chemother"},{"issue":"6","key":"768_CR32","doi-asserted-by":"publisher","first-page":"e0198355","DOI":"10.1371\/journal.pone.0198355","volume":"13","author":"R Hamasuna","year":"2018","unstructured":"Hamasuna R, Le PT, Kutsuna S, Furubayashi K, Matsumoto M, Ohmagari N, et al. Mutations in parC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. PLoS One. 2018;13(6):e0198355.","journal-title":"PLoS One"},{"issue":"5","key":"768_CR33","doi-asserted-by":"publisher","first-page":"e0027822","DOI":"10.1128\/aac.00278-22","volume":"66","author":"GL Murray","year":"2022","unstructured":"Murray GL, Bodiyabadu K, Vodstrcil LA, Machalek DA, Danielewski J, Plummer EL, Garland SM, Whiley DM, Sweeney EL, Bradshaw CS. ParC variants in Mycoplasma genitalium: trends over time and association with Moxifloxacin failure. Antimicrob Agents Chemother. 2022;66(5):e0027822.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"768_CR34","first-page":"1017","volume":"221","author":"GL Murray","year":"2020","unstructured":"Murray GL, Bodiyabadu K, Danielewski J, Garland SM, Machalek DA, Fairley CK, Jensen JS, Williamson DA, Tan LY, Mokany E, et al. Moxifloxacin and sitafloxacin treatment failure in Mycoplasma genitalium infection: association with parC mutation G248T (S83I) and concurrent GyrA mutations. J Infect Dis. 2020;221(6):1017\u201324.","journal-title":"J Infect Dis"},{"issue":"12","key":"768_CR35","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/OLQ.0000000000001493","volume":"48","author":"H Fifer","year":"2021","unstructured":"Fifer H, Merrick R, Pitt R, Yung M, Allen H, Day M, Sinka K, Woodford N, Mohammed H, Brown CS, et al. Frequency and correlates of Mycoplasma genitalium antimicrobial resistance mutations and their association with treatment outcomes: findings from a National Sentinel surveillance pilot in England. Sex Transm Dis. 2021;48(12):951\u20134.","journal-title":"Sex Transm Dis"},{"issue":"3","key":"768_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/sextrans-2020-054897","volume":"98","author":"MJ Day","year":"2022","unstructured":"Day MJ, Cole MJ, Fifer H, Woodford N, Pitt R. Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services. Sex Transm Infect. 2022;98(3):215\u20138.","journal-title":"Sex Transm Infect"},{"issue":"10","key":"768_CR37","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/cid\/ciad405","volume":"77","author":"LE Manhart","year":"2023","unstructured":"Manhart LE, Leipertz G, Soge OO, Jordan SJ, McNeil C, Pathela P, Reno H, Wendel K, Parker A, Geisler WM, et al. Mycoplasma genitalium in the US (MyGeniUS): surveillance data from sexual health clinics in 4 US regions. Clin Infect Dis. 2023;77(10):1449\u201359.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"768_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/tropicalmed10050139","volume":"10","author":"A Copete","year":"2025","unstructured":"Copete A, Herrera M, Suarez-Ariza C, Gitau Z, Arango-Uribe M, Keynan R, Oda C, Singh AE, Skinner S, Spence C, et al. Mycoplasma genitalium infections and associated antimicrobial resistance in Canada, 1980\u20132023. Trop Med Infect Dis. 2025;10(5):139.","journal-title":"Trop Med Infect Dis"},{"issue":"3","key":"768_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/cid\/ciw719","volume":"64","author":"TR Read","year":"2017","unstructured":"Read TR, Fairley CK, Tabrizi SN, Bissessor M, Vodstrcil L, Chow EP, Grant M, Danielewski J, Garland SM, Hocking JS, et al. Azithromycin 1.5\u00a0g over 5 days compared to 1\u00a0g single dose in urethral Mycoplasma genitalium: impact on treatment outcome and resistance. Clin Infect Dis. 2017;64(3):250\u20136.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"768_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/sextrans-2016-053060","volume":"94","author":"P Horner","year":"2018","unstructured":"Horner P, Ingle SM, Garrett F, Blee K, Kong F, Muir P, et al. Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis. Sex Transm Infect. 2018;94(1):14\u201320.","journal-title":"Sex Transm Infect"},{"issue":"2","key":"768_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/sextrans-2015-052414","volume":"93","author":"P Horner","year":"2017","unstructured":"Horner P, Saunders J. Should azithromycin 1\u00a0g be abandoned as a treatment for bacterial stis? The case for and against. Sex Transm Infect. 2017;93(2):85\u20137.","journal-title":"Sex Transm Infect"},{"issue":"6","key":"768_CR42","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/cid\/ciz1031","volume":"17","author":"D Durukan","year":"2019","unstructured":"Durukan D, Read TRH, Murray G, Doyle M, Chow EPF, Vodstrcil LA, Fairley CK, Aguirre I, Mokany E, Tan LY, et al. Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5\u00a0g Azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability. Clin Infect Dis. 2019;17(6):1461\u20138.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"768_CR43","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/cid\/ciy477","volume":"68","author":"TRH Read","year":"2019","unstructured":"Read TRH, Fairley CK, Murray GL, Jensen JS, Danielewski J, Worthington K, Doyle M, Mokany E, Tan L, Chow EPF, et al. Outcomes of Resistance-guided sequential treatment of Mycoplasma genitalium infections: A prospective evaluation. Clin Infect Dis. 2019;68(4):554\u201360.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"768_CR44","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/cid\/ciad057","volume":"76","author":"GL Murray","year":"2023","unstructured":"Murray GL, Plummer EL, Bodiyabadu K, Vodstrcil LA, Huaman JL, Danielewski JA, Chua TP, Machalek DA, Garland S, Doyle M, et al. GyrA mutations in Mycoplasma genitalium and their contribution to Moxifloxacin failure: time for the next generation of resistance-guided therapy. Clin Infect Dis. 2023;76(12):2187\u201395.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"768_CR45","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/cid\/ciab1058","volume":"75","author":"LA Vodstrcil","year":"2022","unstructured":"Vodstrcil LA, Plummer EL, Doyle M, Murray GL, Bodiyabadu K, Jensen JS, Whiley D, Sweeney E, Williamson DA, Chow EPF, et al. Combination therapy for Mycoplasma genitalium, and new insights into the utility of parC mutant detection to improve cure. Clin Infect Dis. 2022;75(5):813\u201323.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"768_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1071\/SH22012","volume":"19","author":"EL Sweeney","year":"2022","unstructured":"Sweeney EL, Whiley DM, Murray GL, Bradshaw CS. Mycoplasma genitalium: enhanced management using expanded resistance-guided treatment strategies. Sex Health. 2022;19(4):248\u201354.","journal-title":"Sex Health"},{"issue":"9","key":"768_CR47","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/S1473-3099(21)00629-0","volume":"22","author":"EL Sweeney","year":"2022","unstructured":"Sweeney EL, Bradshaw CS, Murray GL, Whiley DM. Individualised treatment of Mycoplasma genitalium infection-incorporation of fluoroquinolone resistance testing into clinical care. Lancet Infect Dis. 2022;22(9):e267-70.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"768_CR48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/0956462418816757","volume":"30","author":"AM Glaser","year":"2019","unstructured":"Glaser AM, Geisler WM, Ratliff AE, Xiao L, Waites KB, Gaisa M. Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline. Int J STD AIDS. 2019;30(5):512\u20134.","journal-title":"Int J STD AIDS"},{"issue":"8","key":"768_CR49","doi-asserted-by":"publisher","first-page":"ofad427","DOI":"10.1093\/ofid\/ofad427","volume":"10","author":"EJ Clarke","year":"2023","unstructured":"Clarke EJ, Vodstrcil LA, Plummer EL, Aguirre I, Samra RS, Fairley CK, Chow EPF, Bradshaw CS. Efficacy of Minocycline for the treatment of Mycoplasma genitalium. Open Forum Infect Dis. 2023;10(8):ofad427.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"768_CR50","doi-asserted-by":"publisher","first-page":"ofaa291","DOI":"10.1093\/ofid\/ofaa291","volume":"7","author":"M Doyle","year":"2020","unstructured":"Doyle M, Vodstrcil L, Plummer EP, Aguirre I, Fairley CK, Bradshaw CS. Non-quinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance. Open Forum Infect Dis. 2020;7(8):ofaa291.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"768_CR51","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/cid\/ciaa101","volume":"72","author":"HC Wiesenfeld","year":"2021","unstructured":"Wiesenfeld HC, Meyn LA, Darville T, Macio IS, Hillier SL. A randomized controlled trial of ceftriaxone and doxycycline, with or without metronidazole, for the treatment of acute pelvic inflammatory disease. Clin Infect Dis. 2021;72(7):1181\u20139.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"768_CR52","doi-asserted-by":"publisher","first-page":"e0000623","DOI":"10.1128\/aac.00006-23","volume":"67","author":"GE Wood","year":"2023","unstructured":"Wood GE, Kim CM, Aguila LKT, Cichewicz RH. In vitro susceptibility and resistance of Mycoplasma genitalium to nitroimidazoles. Antimicrob Agents Chemother. 2023;67(4):e0000623.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"768_CR53","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/jac\/dkaf142","volume":"80","author":"K Htaik","year":"2025","unstructured":"Htaik K, Vodstrcil LA, Plummer EL, Matthews LG, Aguirre I, Chow EPF, et al. Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium. J Antimicrob Chemother. 2025;80(7):1878\u201384.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"768_CR54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2402.170902","volume":"24","author":"TRH Read","year":"2018","unstructured":"Read TRH, Jensen JS, Fairley CK, Grant M, Danielewski JA, Su J, Murray GL, Chow EPF, Worthington K, Garland SM, et al. Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium infection. Emerg Infect Dis. 2018;24(2):328\u201335.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"768_CR55","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/iju.12152","volume":"20","author":"R Hamasuna","year":"2013","unstructured":"Hamasuna R. Mycoplasma genitalium in male urethritis: diagnosis and treatment in Japan. Int J Urol. 2013;20(7):676\u201384.","journal-title":"Int J Urol"},{"issue":"8","key":"768_CR56","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3201\/eid2608.191806","volume":"26","author":"D Durukan","year":"2020","unstructured":"Durukan D, Doyle M, Murray G, Bodiyabadu K, Vodstrcil L, Chow EPF, et al. Doxycycline and sitafloxacin combination therapy for treating highly resistant Mycoplasma genitalium. Emerg Infect Dis. 2020;26(8):1870\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"768_CR57","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/jac\/dkae403","volume":"80","author":"N Ando","year":"2025","unstructured":"Ando N, Mizushima D, Takano M, Mitobe M, Kobayashi K, Kubota H, Miyake H, Suzuki J, Sadamasu K, Aoki T, et al. Prolonged sitafloxacin and Doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium. J Antimicrob Chemother. 2025;80(1):247\u201353.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"768_CR58","doi-asserted-by":"publisher","first-page":"e0365422","DOI":"10.1128\/spectrum.03654-22","volume":"10","author":"KB Waites","year":"2022","unstructured":"Waites KB, Crabb DM, Atkinson TP, Geisler WM, Xiao L. Omadacycline is highly active in vitro against Mycoplasma genitalium. Microbiol Spectr. 2022;10(6):e0365422.","journal-title":"Microbiol Spectr"},{"issue":"10","key":"768_CR59","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1093\/jac\/dkaf272","volume":"80","author":"S Skovmand","year":"2025","unstructured":"Skovmand S, Norgaard C, Salado-Rasmussen K, Jensen JS. In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium. J Antimicrob Chemother. 2025;80(10):2676\u201381.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"768_CR60","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/iju.70046","volume":"32","author":"Y Kobori","year":"2025","unstructured":"Kobori Y, Yoshida N, Manda K, Onoe Y, Hamasuna R. Outcomes of sequential therapy with Minocycline and sitafloxacin versus sitafloxacin monotherapy for Mycoplasma genitalium infections. Int J Urol. 2025;32(6):767\u20139.","journal-title":"Int J Urol"},{"key":"768_CR61","unstructured":"Vanbaelen T, \u2018t Huis. Veld D, Visser BJ, De Baetselier I, Van Praet JT, Manoharan-Basil SS, Van den Bossche D, Kenyon C: Combination therapy for multidrug-resistant Mycoplasma genitalium infections: a case series. Sex Transm Infect 2025, online ahead of print."},{"issue":"11","key":"768_CR62","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1097\/OLQ.0000000000001415","volume":"48","author":"R Palich","year":"2021","unstructured":"Palich R, Gardette M, Bebear C, Caumes E, Pereyre S, Monsel G. Initial failure of Pristinamycin treatment in a case of Multidrug-Resistant Mycoplasma genitalium urethritis eventually treated by sequential therapy. Sex Transm Dis. 2021;48(11):e163-4.","journal-title":"Sex Transm Dis"},{"issue":"11","key":"768_CR63","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/0956462420905269","volume":"31","author":"L Yang","year":"2020","unstructured":"Yang L, Ke W. Azithromycin, minocycline, Moxifloxacin and spectinomycin failure in a case with persistent Mycoplasma genitalium infection in Guangzhou, China. Int J STD AIDS. 2020;31(11):1106\u20139.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"768_CR64","doi-asserted-by":"publisher","first-page":"e0134624","DOI":"10.1128\/aac.01346-24","volume":"69","author":"K Salado-Rasmussen","year":"2025","unstructured":"Salado-Rasmussen K, Norgaard C, Pedersen TR, Paukner S, Jensen JS. In vitro test of the novel antibiotic lefamulin alone and in combination with Doxycycline against Mycoplasma genitalium. Antimicrob Agents Chemother. 2025;69(1):e0134624.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"768_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/sextrans-2024-056338","volume":"101","author":"MS Ramchandani","year":"2025","unstructured":"Ramchandani MS, Plummer EL, Parker A, Vodstrcil LA, Soge OO, Aguirre I, Kim J, Hughes JP, Barbee LA, Jensen JS, et al. Lefamulin for Mycoplasma genitalium treatment failure in Australia and the USA: a case series and pilot open-label parallel arm randomised trial. Sex Transm Infect. 2025;101(2):101\u20138.","journal-title":"Sex Transm Infect"},{"issue":"10489","key":"768_CR66","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(25)00628-2","volume":"405","author":"JDC Ross","year":"2025","unstructured":"Ross JDC, Wilson J, Workowski KA, Taylor SN, Lewis DA, Gatsi S, Flight W, Scangarella-Oman NE, Jakielaszek C, Lythgoe D, et al. Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study. Lancet. 2025;405(10489):1608\u201320.","journal-title":"Lancet"},{"issue":"19","key":"768_CR67","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","volume":"379","author":"SN Taylor","year":"2018","unstructured":"Taylor SN, Marrazzo J, Batteiger BE, Hook EW 3rd, Sena AC, Long J, Wierzbicki MR, Kwak H, Johnson SM, Lawrence K, et al. Single-Dose Zoliflodacin (ETX0914) for treatment of urogenital gonorrhea. N Engl J Med. 2018;379(19):1835\u201345.","journal-title":"N Engl J Med"},{"issue":"1","key":"768_CR68","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1080\/22221751.2020.1775498","volume":"9","author":"JS Jensen","year":"2020","unstructured":"Jensen JS, Norgaard C, Scangarella-Oman N, Unemo M. In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with Doxycycline against drug-resistant and -susceptible Mycoplasma genitalium. Emerg Microbes Infect. 2020;9(1):1388\u201392.","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"768_CR69","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/jac\/dky022","volume":"73","author":"AC Damiao Gouveia","year":"2018","unstructured":"Damiao Gouveia AC, Unemo M, Jensen JS. In vitro activity of Zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains. J Antimicrob Chemother. 2018;73(5):1291\u20134.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"768_CR70","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1128\/jcm.34.2.286-291.1996","volume":"34","author":"JS Jensen","year":"1996","unstructured":"Jensen JS, Hansen HT, Lind K. Isolation of Mycoplasma genitalium strains from the male urethra. J Clin Microbiol. 1996;34(2):286\u201391.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"768_CR71","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1128\/CMR.00006-11","volume":"24","author":"D Taylor-Robinson","year":"2011","unstructured":"Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicolored butterfly. Clin Microbiol Rev. 2011;24(3):498\u2013514.","journal-title":"Clin Microbiol Rev"},{"issue":"9308","key":"768_CR72","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0140-6736(02)07848-0","volume":"359","author":"CR Cohen","year":"2002","unstructured":"Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet. 2002;359(9308):765\u20136.","journal-title":"Lancet"},{"issue":"6","key":"768_CR73","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/sextrans-2017-053376","volume":"94","author":"BD Taylor","year":"2018","unstructured":"Taylor BD, Zheng X, O\u2019Connell CM, Wiesenfeld HC, Hillier SL, Darville T. Risk factors for Mycoplasma genitalium endometritis and incident infection: a secondary data analysis of the T cell response against chlamydia (TRAC) study. Sex Transm Infect. 2018;94(6):414\u201320.","journal-title":"Sex Transm Infect"},{"issue":"10","key":"768_CR74","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/cid\/ciaa419","volume":"71","author":"J Lewis","year":"2020","unstructured":"Lewis J, Horner PJ, White PJ. Incidence of pelvic inflammatory disease associated with Mycoplasma genitalium infection: evidence synthesis of cohort study data. Clin Infect Dis. 2020;71(10):2719\u201322.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"768_CR75","first-page":"561","volume":"23","author":"D Taylor-Robinson","year":"1987","unstructured":"Taylor-Robinson D, Furr PM, Tully JG, Barile MF, Moller BR. Animal models of Mycoplasma genitalium urogenital infection. Isr J Med Sci. 1987;23(6):561\u20134.","journal-title":"Isr J Med Sci"},{"issue":"6","key":"768_CR76","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/sti.2005.015701","volume":"81","author":"CR Cohen","year":"2005","unstructured":"Cohen CR, Mugo NR, Astete SG, Odondo R, Manhart LE, Kiehlbauch JA, Stamm WE, Waiyaki PG, Totten PA. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect. 2005;81(6):463\u20136.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"768_CR77","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/humrep\/del455","volume":"22","author":"A Baczynska","year":"2007","unstructured":"Baczynska A, Funch P, Fedder J, Knudsen HJ, Birkelund S, Christiansen G. Morphology of human fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis\u2013in vitro organ culture study. Hum Reprod. 2007;22(4):968\u201379.","journal-title":"Hum Reprod"},{"issue":"9","key":"768_CR78","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/humrep\/16.9.1866","volume":"16","author":"HF Clausen","year":"2001","unstructured":"Clausen HF, Fedder J, Drasbek M, Nielsen PK, Toft B, Ingerslev HJ, et al. Serological investigation of Mycoplasma genitalium in infertile women. Hum Reprod. 2001;16(9):1866\u201374.","journal-title":"Hum Reprod"},{"issue":"3","key":"768_CR79","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/sextrans-2021-055352","volume":"98","author":"C Frenzer","year":"2022","unstructured":"Frenzer C, Egli-Gany D, Vallely LM, Vallely AJ, Low N. Adverse pregnancy and perinatal outcomes associated with Mycoplasma genitalium: systematic review and meta-analysis. Sex Transm Infect. 2022;98(3):222\u20137.","journal-title":"Sex Transm Infect"},{"issue":"9","key":"768_CR80","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.medj.2024.05.007","volume":"5","author":"MJL Scoullar","year":"2024","unstructured":"Scoullar MJL, Melepia P, Peach E, Fidelis R, Supsup H, Davidson EM, Boeuf P, Bradshaw CS, Fehler G, Hezeri P, et al. Mycoplasma genitalium in pregnancy, including specific co-infections, is associated with lower birthweight: A prospective cohort study. Med. 2024;5(9):1123\u201336. e1123.","journal-title":"Med"},{"issue":"8","key":"768_CR81","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/sextrans-2019-054310","volume":"96","author":"RL Latimer","year":"2020","unstructured":"Latimer RL, Shilling HS, Vodstrcil LA, Machalek DA, Fairley CK, Chow EPF, et al. Prevalence of Mycoplasma genitalium by anatomical site in men who have sex with men: a systematic review and meta-analysis. Sex Transm Infect. 2020;96(8):563\u201370.","journal-title":"Sex Transm Infect"},{"issue":"7","key":"768_CR82","doi-asserted-by":"publisher","first-page":"ofab137","DOI":"10.1093\/ofid\/ofab137","volume":"8","author":"EPF Chow","year":"2021","unstructured":"Chow EPF, Lee D, Bond S, Fairley CK, Maddaford K, Wigan R, Fehler G, Lange SA, De Petra V, Bissessor M, et al. Nonclassical pathogens as causative agents of proctitis in men who have sex with men. Open Forum Infect Dis. 2021;8(7):ofab137.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"768_CR83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/sti.2009.038190","volume":"86","author":"S Soni","year":"2010","unstructured":"Soni S, Alexander S, Verlander N, Saunders P, Richardson D, Fisher M, et al. The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex Transm Infect. 2010;86(1):21\u20134.","journal-title":"Sex Transm Infect"},{"issue":"3","key":"768_CR84","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1442-2042.2011.02917.x","volume":"19","author":"S Ito","year":"2012","unstructured":"Ito S, Tsuchiya T, Yasuda M, Yokoi S, Nakano M, Deguchi T. Prevalence of genital Mycoplasmas and Ureaplasmas in men younger than 40 years-of-age with acute epididymitis. Int J Urol. 2012;19(3):234\u20138.","journal-title":"Int J Urol"},{"issue":"1","key":"768_CR85","doi-asserted-by":"publisher","first-page":"103","DOI":"10.37201\/req\/082.2022","volume":"36","author":"D Fernandez Vecilla","year":"2023","unstructured":"Fernandez Vecilla D, Aragon Diez J, Nieto Toboso MC, Rossello Soria J. Diaz de tuesta Del Arco JL: could Mycoplasma genitalium be involved in chronic granulomatous orchiepididymits? Case report and literature review. Rev Esp Quimioter. 2023;36(1):103\u20136.","journal-title":"Rev Esp Quimioter"},{"issue":"7","key":"768_CR86","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1046\/j.1464-410x.1999.00252.x","volume":"84","author":"JH Eickhoff","year":"1999","unstructured":"Eickhoff JH, Frimodt-Moller N, Walter S, Frimodt-Moller C. A double-blind, randomized, controlled multicentre study to compare the efficacy of ciprofloxacin with pivampicillin as oral therapy for epididymitis in men over 40 years of age. BJU Int. 1999;84(7):827\u201334.","journal-title":"BJU Int"},{"issue":"1","key":"768_CR87","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/sti.2010.044487","volume":"87","author":"PJ Horner","year":"2011","unstructured":"Horner PJ, Taylor-Robinson D. Association of Mycoplasma genitalium with balanoposthitis in men with non-gonococcal urethritis. Sex Transm Infect. 2011;87(1):38\u201340.","journal-title":"Sex Transm Infect"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-025-00768-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:04:24Z","timestamp":1769609064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-025-00768-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1007\/s11904-025-00768-7","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for collection of data on trends in moxifloxacin use and cure at Melbourne Sexual Health Centre was provided by the Alfred Hospital Ethics Committee, Melbourne, Australia (ID: 232\/16).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"CSB receives Australian government funding from the National Health and Medical Research Council and Australian Research Council that supports her investigator led research and funds LAV. KH is supported by an Australian Government Department of Higher Education Research Training Scholarship and Royal Australasian College of Physician Research Entry Scholarship. There are no other conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}